» Articles » PMID: 17408212

Eudragit-coated Pectin Microspheres of 5-fluorouracil for Colon Targeting

Overview
Publisher Springer
Specialty Pharmacology
Date 2007 Apr 6
PMID 17408212
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

An objective of the present investigation was to prepare and evaluate Eudragit-coated pectin microspheres for colon targeting of 5-fluorouracil (FU). Pectin microspheres were prepared by emulsion dehydration method using different ratios of FU and pectin (1:3 to 1:6), stirring speeds (500-2000 rpm) and emulsifier concentrations (0.75%-1.5% wt/vol). The yield of preparation and the encapsulation efficiencies were high for all pectin microspheres. Microspheres prepared by using drug:polymer ratio 1:4, stirring speed 1000 rpm, and 1.25% wt/vol concentration of emulsifying agent were selected as an optimized formulation. Eudragit-coating of pectin microspheres was performed by oil-in-oil solvent evaporation method using coat:core ratio (5:1). Pectin microspheres and Eudragit-coated pectin microspheres were evaluated for surface morphology, particle size and size distribution, swellability, percentage drug entrapment, and in vitro drug release in simulated gastrointestinal fluids (SGF). The in vitro drug release study of optimized formulation was also performed in simulated colonic fluid in the presence of 2% rat cecal content. Organ distribution study in albino rats was performed to establish the targeting potential of optimized formulation in the colon. The release profile of FU from Eudragit-coated pectin microspheres was pH dependent. In acidic medium, the release rate was much slower; however, the drug was released quickly at pH 7.4. It is concluded from the present investigation that Eudragit-coated pectin microspheres are promising controlled release carriers for colon-targeted delivery of FU.

Citing Articles

Enhancing Pectin Particles with Polymer Additives: Mitigating Rumen Degradation and Minimizing Yellowish Milk Color in Grazed Cows.

Vera-Vazquez F, Ramirez-Bribiesca J, Cruz-Monterrosa R, Crosby-Galvan M, Barcena-Gama J, Ramirez D Polymers (Basel). 2024; 16(1).

PMID: 38201771 PMC: 10780586. DOI: 10.3390/polym16010106.


State of Innovation in Alginate-Based Materials.

Adamiak K, Sionkowska A Mar Drugs. 2023; 21(6).

PMID: 37367678 PMC: 10302983. DOI: 10.3390/md21060353.


Advances in Polysaccharide-Based Oral Colon-Targeted Delivery Systems: The Journey So Far and the Road Ahead.

Ibrahim I Cureus. 2023; 15(1):e33636.

PMID: 36788847 PMC: 9912363. DOI: 10.7759/cureus.33636.


Eudragit-Coated Sporopollenin Exine Microcapsules (SEMC) of L. of 5-Fluorouracil for Colon-Specific Drug Delivery.

Raish M, Kalam M, Ahmad A, Shahid M, Ansari M, Ahad A Pharmaceutics. 2021; 13(11).

PMID: 34834336 PMC: 8621040. DOI: 10.3390/pharmaceutics13111921.


Formulation and optimisation of lamivudine-loaded Eudragit S 100 polymer-coated pectin microspheres for colon-specific delivery.

Vilas S, Thilagar S IET Nanobiotechnol. 2021; 15(1):90-99.

PMID: 34694732 PMC: 8675772. DOI: 10.1049/nbt2.12010.


References
1.
Yang Q . Biodegradable progesterone microsphere delivery system for osteoporosis therapy. Drug Dev Ind Pharm. 2000; 26(1):61-70. DOI: 10.1081/ddc-100100328. View

2.
Rai G, Jain S, Agrawal S, Bhadra S, Pancholi S, Agrawal G . Chitosan hydrochloride based microspheres of albendazole for colonic drug delivery. Pharmazie. 2005; 60(2):131-4. View

3.
Esposito E, Cortesi R, Luca G, Nastruzzi C . Pectin-based microspheres: a preformulatory study. Ann N Y Acad Sci. 2002; 944:160-79. View

4.
Riley S, Turnberg L . Sulphasalazine and the aminosalicylates in the treatment of inflammatory bowel disease. Q J Med. 1990; 75(278):551-62. View

5.
Bartalsky A . Salicylazobenzoic acid in ulcerative colitis. Lancet. 1982; 1(8278):960. DOI: 10.1016/s0140-6736(82)91956-0. View